# CureVac N.V. (CVAC)

Source: https://www.quantisnow.com/company/CVAC
Generated: 2026-11-08T19:58:36.042Z

- Ticker: CVAC
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2020
- Website: curevac.com

## About

CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidate against COVID-19; CV7202, a prophylactic mRNA-based vaccine, which is in Phase 1 clinical trial for rabies virus glycoprotein; vaccine for lassa yellow fever; vaccine for respirational syncytial virus; CV7301, a second-generation lipid nanoparticle flu vaccine; and vaccines for rota, malaria, and universal influenza. The company also develops RNA-based cancer immunotherapies, including CV8102, which is in Phase 1 clinical trial for treating cutaneous melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck; and CV9202 (BI 1361849), a self-adjuvanting mRNA vaccine that is in Phase 1 clinical trial for non-small cell lung cancer, as well as tumor associated antigens and shared neo-antigens. In addition, it is developing protein-based therapies for Cas9 gene-editing, ocular diseases, and lung respiratory diseases, as well as therapeutic antibodies. The company was founded in 2000 and is headquartered in Tübingen, Germany.

## Latest CVAC news and filings

- 2026-01-16 13:00 UTC [SEC Form 15-12G filed by CureVac N.V.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-curevac-nv-6351492)
- 2026-01-07 21:15 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by CureVac N.V.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-curevac-nv-6341214)
- 2026-01-06 15:25 UTC [SEC Form 25-NSE filed by CureVac N.V.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-curevac-nv-6337716)
- 2026-01-06 11:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by CureVac N.V.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-curevac-nv-6337033)
- 2025-12-18 21:16 UTC [SEC Schedule TOT] [Amendment: SEC Form SC TO-T/A filed by CureVac N.V.](https://www.quantisnow.com/insight/amendment-sec-form-sc-to-ta-filed-by-curevac-nv-6322213)
- 2025-12-18 21:01 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by CureVac N.V.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-curevac-nv-6321959)
- 2025-12-18 09:45 UTC [BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field](https://www.quantisnow.com/insight/biontech-closes-acquisition-of-curevac-nv-including-subsequent-offering-period-6320994)
- 2025-12-12 21:01 UTC [Amendment: SEC Form SCHEDULE 13D/A filed by CureVac N.V.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-curevac-nv-6313946)
- 2025-12-12 18:40 UTC [Amendment: SEC Form SCHEDULE 13D/A filed by CureVac N.V.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-curevac-nv-6313800)
- 2025-12-05 21:23 UTC [Amendment: SEC Form SCHEDULE 13D/A filed by CureVac N.V.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-curevac-nv-6305171)
- 2025-12-05 15:10 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by CureVac N.V.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-curevac-nv-6304638)
- 2025-12-03 21:50 UTC [SEC Schedule TOT] [Amendment: SEC Form SC TO-T/A filed by CureVac N.V.](https://www.quantisnow.com/insight/amendment-sec-form-sc-to-ta-filed-by-curevac-nv-6301957)
- 2025-12-03 21:32 UTC [SEC Form 425] [SEC Form 425 filed by CureVac N.V.](https://www.quantisnow.com/insight/sec-form-425-filed-by-curevac-nv-6301813)
- 2025-12-03 14:01 UTC [Public Offering] [BioNTech Achieves Minimum Condition in CureVac Exchange Offer](https://www.quantisnow.com/insight/biontech-achieves-minimum-condition-in-curevac-exchange-offer-6301008)
- 2025-11-26 21:56 UTC [SEC Schedule TOT] [Amendment: SEC Form SC TO-T/A filed by CureVac N.V.](https://www.quantisnow.com/insight/amendment-sec-form-sc-to-ta-filed-by-curevac-nv-6295475)
- 2025-11-26 21:34 UTC [SEC Form 425] [SEC Form 425 filed by CureVac N.V.](https://www.quantisnow.com/insight/sec-form-425-filed-by-curevac-nv-6295380)
- 2025-11-26 15:13 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by CureVac N.V.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-curevac-nv-6294703)
- 2025-11-26 15:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by CureVac N.V.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-curevac-nv-6294698)
- 2025-11-26 12:30 UTC [Public Offering] [BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration](https://www.quantisnow.com/insight/biontech-shares-progress-on-exchange-offer-for-curevac-shares-and-6294460)
- 2025-11-26 00:05 UTC [Market Insight] [CureVac Announces Voting Results of Extraordinary General Meeting](https://www.quantisnow.com/insight/curevac-announces-voting-results-of-extraordinary-general-meeting-6294183)
- 2025-11-25 16:28 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by CureVac N.V.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-curevac-nv-6293190)
- 2025-11-24 15:52 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by CureVac N.V.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-curevac-nv-6291385)
- 2025-11-24 14:24 UTC [SEC Form 6-K] [SEC Form 6-K filed by CureVac N.V.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-curevac-nv-6291378)
- 2025-11-24 12:30 UTC [Market Insight] [CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2025 and Provides Business Updates](https://www.quantisnow.com/insight/curevac-announces-financial-results-for-the-third-quarter-and-first-6291035)
- 2025-11-12 13:01 UTC [SEC Form 425] [SEC Form 425 filed by CureVac N.V.](https://www.quantisnow.com/insight/sec-form-425-filed-by-curevac-nv-6272997)
- 2025-11-12 13:00 UTC [SEC Form 425] [SEC Form 425 filed by CureVac N.V.](https://www.quantisnow.com/insight/sec-form-425-filed-by-curevac-nv-6272987)
- 2025-10-27 10:01 UTC [SEC Form 6-K] [SEC Form 6-K filed by CureVac N.V.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-curevac-nv-6245112)
- 2025-10-23 01:35 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by CureVac N.V.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-curevac-nv-6242373)
- 2025-10-22 21:23 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by CureVac N.V.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-curevac-nv-6242121)
- 2025-10-22 20:27 UTC [SEC Schedule TOT] [Amendment: SEC Form SC TO-T/A filed by CureVac N.V.](https://www.quantisnow.com/insight/amendment-sec-form-sc-to-ta-filed-by-curevac-nv-6241847)
- 2025-10-22 20:05 UTC [SEC Form 425] [SEC Form 425 filed by CureVac N.V.](https://www.quantisnow.com/insight/sec-form-425-filed-by-curevac-nv-6241587)
- 2025-10-22 20:03 UTC [SEC Form 425] [SEC Form 425 filed by CureVac N.V.](https://www.quantisnow.com/insight/sec-form-425-filed-by-curevac-nv-6241507)
- 2025-10-22 10:45 UTC [Public Offering] [BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.](https://www.quantisnow.com/insight/biontech-commences-public-exchange-offer-for-all-outstanding-shares-of-6240744)
- 2025-10-21 21:00 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9 filed by CureVac N.V.](https://www.quantisnow.com/insight/sec-form-sc-14d9-filed-by-curevac-nv-6240436)
- 2025-10-21 20:29 UTC [SEC Schedule TOT] [SEC Form SC TO-T filed by CureVac N.V.](https://www.quantisnow.com/insight/sec-form-sc-to-t-filed-by-curevac-nv-6240272)
- 2025-10-20 20:31 UTC [SEC Form 425] [SEC Form 425 filed by CureVac N.V.](https://www.quantisnow.com/insight/sec-form-425-filed-by-curevac-nv-6238823)
- 2025-10-20 20:30 UTC [SEC Form 425] [SEC Form 425 filed by CureVac N.V.](https://www.quantisnow.com/insight/sec-form-425-filed-by-curevac-nv-6238820)
- 2025-08-15 20:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by CureVac N.V.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-curevac-nv-6168312)
- 2025-08-15 11:50 UTC [Market Insight] [CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates](https://www.quantisnow.com/insight/curevac-announces-financial-results-for-the-second-quarter-and-first-6167753)
- 2025-08-13 22:05 UTC [SEC Form SCHEDULE 13D filed by CureVac N.V.](https://www.quantisnow.com/insight/sec-form-schedule-13d-filed-by-curevac-nv-6163892)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/CVAC
- Earnings history: https://www.quantisnow.com/earnings/CVAC
- Dividend history: https://www.quantisnow.com/dividends/CVAC
- Insider transactions: https://www.quantisnow.com/insiders/CVAC
- Options chain: https://www.quantisnow.com/options/CVAC
- SEC 8-K filings only: https://www.quantisnow.com/company/CVAC/8-k
- RSS and alerts for CVAC: https://www.quantisnow.com/docs/rss-feeds.md